|
News
31 August 2003
Concern over future prices and availability of medicines
There is concern that new regulations prompted by the EU may
mean higher prices for some medicinals with others disappearing
from the market.
While all pharmaceutical imports into Malta were always subject
to some form of registration, EU membership will mean that all
medicines presently imported will have to be registered anew.
The guidelines for registration have as yet not been issued and
importers are concerned as more than 6,500 products will have
to go through the process prior to the end of 2006.
While the fees payable for registration have not yet been made
public there is concern that certain older products that are sold
relatively cheaply, will be withdrawn from the market.
Importers claim it will not be commercially viable for the manufacturers
to pay the fees in view of the relatively small quantities sold
on the islands. If the medicinals are to be imported, the fees
would be worked into the price, resulting in an increase.
MaltaToday has learned that there may be a requirement that packs
sold in Malta bear a local registration number. In view of the
low quantities sold on the islands it may not be feasible for
manufacturers to print this on the packs and according to pharmaceutical
importers who preferred to remain anonymous, the addition of a
sticker or stamp may give rise to abuse.
Registration fees for products originating outside the EU are
expected to be substantial. Since the government purchases millions
of Liri worth of medicines, all of which fall into this category,
these will probably have to be purchased at higher prices from
sources within the EU.
If the registration fees are paid, prices quoted would have to
reflect the costs of registration.
It will be a requirement that all medicines sold in Malta are
to have packs in the English language. However, many packs currently
on sale in Malta are not EU packs, but international packs that
are suitable to be sold in Maltese and similar humid climatic
conditions.
It is of concern that the full documentation required is not usually
available for these packs, while on the other hand, the packs
for which full documentation is available, are often not prepared
to withstand our climatic conditions.
Most EU countries are financially strong enough to manufacture
a pack specifically for their requirements. However, most of the
times, Maltese importers can only rely on English or international
packs since they are the only ones to be described in the English
language.
England is, however, in a completely different climatic zone to
us. Pharmaceutical importers, who preferred to remain anonymous
told MaltaToday they also question government's policy on parallel
importation. Parallel important allows a licensed importer to
import a product that is essentially the same as another one that
has a market authorisation. While this stand is meant to protect
the consumer, it is more often the retail outlet that is benefiting,
it was claimed.
|